4.0 Article

Control of viral replication after cessation of HAART

Journal

AIDS RESEARCH AND THERAPY
Volume 8, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/1742-6405-8-6

Keywords

-

Funding

  1. Fund for Scientific Research Flanders (FWO) [G.0.370.08.N.10]

Ask authors/readers for more resources

We describe two patients who did not experience a viral rebound after cessation of HAART which was initiated for progressive disease. CD4 T-cell count remained stable in one patient and progressively declined in the other, despite apparent viral control. We failed to identify any immune activation or genetic markers that could offer an explanation for this unusual secondary controller status. But their viruses are clearly less fit compared to viruses from rebounders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

Repeat syphilis has a different immune response compared with initial syphilis: an analysis of biomarker kinetics in two cohorts

Chris Kenyon, Achilleas Tsoumanis, Kara Osbak, Marjan van Esbroeck, Eric Florence, Tania Crucitti, Luc Kestens

SEXUALLY TRANSMITTED INFECTIONS (2018)

Article Immunology

Clinical Utility of the Nonstructural 1 Antigen Rapid Diagnostic Test in the Management of Dengue in Returning Travelers With Fever

Ralph Huits, Patrick Soentjens, Ula Maniewski-Kelner, Caroline Theunissen, Steven Van Den Broucke, Eric Florence, Jan Clerinx, Erika Vlieghe, Jan Jacobs, Lieselotte Cnops, Dorien Van Den Bossche, Marjan Van Esbroeck, Emmanuel Bottieau

OPEN FORUM INFECTIOUS DISEASES (2017)

Article Infectious Diseases

HIV testing for key populations in Europe: A decade of technological innovation and patient empowerment complement the role of health care professionals

T. Platteau, J. van Lankveld, L. Apers, K. Fransen, J. Rockstroh, E. Florence

HIV MEDICINE (2018)

Article Medicine, General & Internal

Long-term use of darunavir/ritonavir-containing regimens in daily practice in Belgium: retrospective observational cohort data of 1701 HIV-patients

Stephane De Wit, Eric Florence, Linos Vandekerckhove, Bernard Vandercam, Jean-Christophe Goffard, Eric Van Wijngaerden, Michel Moutschen, Remy Demeester, Pushpike Thilakarathne, Hilde Piryns

ACTA CLINICA BELGICA (2018)

Article Medicine, General & Internal

Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017

Agnes Libois, Eric Florence, Inge Derdelinckx, Jean Cyr Yombi, Sophie Henrard, Francoise Uurlings, Stefaan Vandecasteele, Sabine D. Allard, Remy Demeester, Filip Van Wanzeele, Nathalie Ausselet, Stephane De Wit

ACTA CLINICA BELGICA (2018)

Article Medicine, General & Internal

Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients

Stephane De Wit, Eric Florence, Linos Vandekerkhove, Jean-Christophe Goffard, Bernard Vandercam, Eric Van Wijngaerden, Michel Moutschen, Remy Demeester, Patrick Lacor, Marc Delforge, Maartje van Frankenhuijsen, Paul Lacante

ACTA CLINICA BELGICA (2019)

Article Multidisciplinary Sciences

A randomized trial comparing concise and standard consent forms in the START trial

Christine Grady, Giota Touloumi, A. Sarah Walker, Mary Smolskis, Shweta Sharma, Abdel G. Babiker, Nikos Pantazis, Jorge Tavel, Eric Florence, Adriana Sanchez, Fleur Hudson, Antonios Papadopoulos, Ezekiel Emanuel, Megan Clewett, David Munroe, Eileen Denning

PLOS ONE (2017)

Article Multidisciplinary Sciences

A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening

Anja De Weggheleire, Sokkab An, Irith De Baetselier, Pisith Soeung, Huy Keath, Veasna So, Sreyphors Ros, Syna Teav, Bart Smekens, Jozefien Buyze, Eric Florence, Johan van Griensven, Sopheak Thai, Sven Francque, Lutgarde Lynen

PLOS ONE (2017)

Article Immunology

Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations

Kamilla Gronborg Laut, Leah Shepherd, Magnus Gottfredsson, Dalibor Sedlacek, Brygida Knysz, Josip Begovac, Roxana Radoi, Brigitte Schmied, Nikoloz Chkhartishvili, Eric Florence, Matti Ristola, Gerd Faetkenheuer, Fiona Mulcahy, Patrick Schmid, Elena Kuzovatova, Dzmitry Paduta, Jelena Smidt, Pere Domingo, Janos Szlavik, Jens Lundgren, Amanda Mocroft, Ole Kirk

Article Infectious Diseases

Increases in condomless chemsex associated with HIV acquisition in MSM but not heterosexuals attending a HIV testing center in Antwerp, Belgium

Chris Kenyon, Kristien Wouters, Tom Platteau, Jozefien Buyze, Eric Florence

AIDS RESEARCH AND THERAPY (2018)

Article Microbiology

Should We Screen HIV-Positive Migrants for Strongyloidiasis?

Caroline Theunissen, Emmanuel Bottieau, Marjan Van Esbroeck, Achilleas Tsoumanis, Eric Florence

PATHOGENS (2020)

Article Infectious Diseases

Incidence rate, predictors and outcomes of interruption of HIV care: nationwide results from the Belgian HIV cohort

D. Van Beckhoven, E. Florence, S. De Wit, C. Wyndham-Thomas, A. Sasse, H. Van Oyen, J. Macq

HIV MEDICINE (2020)

Article Environmental Sciences

Harm Reduction Practices and Needs in a Belgian Chemsex Context: Findings from a Qualitative Study

Corinne Herrijgers, Karolien Poels, Heidi Vandebosch, Tom Platteau, Jacques van Lankveld, Eric Florence

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Article Infectious Diseases

The hepatitis C cascade of care in the Belgian HIV population: One step closer to elimination

Dana Busschots, Cecile Kremer, Ozgur M. Koc, Leen Heyens, Rob Bielen, Ludwig Apers, Eric Florence, Peter Messiaen, Kristel Van Laethem, Eric Van Wijngaerden, Frederik Nevens, Niel Hens, Geert Robaeys

Summary: This study investigated the HCV infection situation of 4607 PLHIV in Belgium, with high rates of treatment initiation and sustained virologic response (SVR). Implementation of a national HCV register for tracking progress and yearly screening is crucial for achieving HCV elimination in PLHIV by 2030.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Health Care Sciences & Services

Using Intervention Mapping to Develop an mHealth Intervention to Support Men Who Have Sex With Men Engaging in Chemsex (Budd): Development and Usability Study

Corinne Herrijgers, Tom Platteau, Heidi Vandebosch, Karolien Poels, Eric Florence

Summary: This study developed a mobile health intervention tool named Budd using the intervention mapping protocol to support and inform MSM engaging in chemsex, reducing negative impacts, and promoting more reasoned participation.

JMIR RESEARCH PROTOCOLS (2022)

No Data Available